NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT03109158 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

DRUG: NC-6004
DRUG: Cetuximab
DRUG: 5-FU

Sponsor

NanoCarrier Co., Ltd.